Minnesota HF2476 modifies restrictions on the sale of over-the-counter allergy medicines containing methamphetamine precursor drugs.
Minnesota HF2476 amends the state's controlled substances law to modify restrictions on the sale of over-the-counter allergy medicines containing methamphetamine precursor drugs. The bill limits over-the-counter sales to packages containing no more than three 3-6/10 grams of methamphetamine precursor drugs, calculated in terms of ephedrine base or pseudoephedrine base. It also restricts the total amount of such drugs that can be acquired in a 30-day period to six 7-2/10 grams.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.